Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Human Pathology|December 27, 2014
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironmentSandra P D'Angelo, Alexander N Shoushtari, Narasimhan P Agaram, et al.
Oncology|June 6, 2015
Outcomes of Systemic Therapy for Patients with Metastatic AngiosarcomaSandra P D'Angelo, Rodrigo R Munhoz, Deborah Kuk, et al.
British Journal of Haematology|April 27, 2007
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysisAndrew M Evens, Jeffrey Cilley, Taylor Ortiz, et al.
The Oncologist|August 10, 2019
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF AlterationsAditya Bardia, Mrinal Gounder, Jordi Rodon, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapyYaniv Kazansky, Daniel Cameron, Helen S Mueller, et al.
The Lancet. Oncology|November 29, 2008
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jawBeatrice J Edwards, Mrinal Gounder, June M McKoy, et al.
The Oncologist|June 20, 2019
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal TumorEvan Rosenbaum, Ciara Kelly, Sandra P D'Angelo, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2021
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulationValentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical OutcomeEvan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Pageof 4